A Novel Multiplex Elisa Assay for Evaluating Patients with Gross Hematuria for Bladder Cancer.
- Clements University Hospital
- UT Southwestern Ambulatory Services
Yair Lotan, M.D.
This is a phase 3 single arm study comparing the diagnostic capabilities of multiplex eLiSa assay to VuC and nMP22 BladderChek to reference standard of cystoscopy in participants with gross hematuria.
Age 18 years or older
Have documented or reported gross hematuria within 3 month of study enrollment
Willing and able to give written informed consent